Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Mandros, D. Ntelios, I. Tassiou, P. Malindretos, E. Potolidis, G. Tzelepis (Volos, Athens, Greece). Long term administration of anti-TNFalpha in ankylosing spondylitis (AS) patients – A post-hoc analysis. Eur Respir J 2013; 42: Suppl. 57, 1799

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of lungs in ankylosing spondylitis patients Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Use of home non-invasive ventilation (NIV) in patients with ankylosing spondylitis (AS) Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 Evaluation of respiratory impedance in patients with ankylosing spondylitis Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease Year: 2020 Does CTLA-4 and CD-28 polymorphism affect the lung involvement in Turkish ankylosing spondylitis patients?? Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab Source: International Congress 2016 – Sarcoidosis Year: 2016 Rehabilitation of pulmonary dysfunction in patients with ankylosing spondylitis Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011 Patient with ankylosing spondylitis and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Adalimumab and etanercept induced asthma Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: "REDUCE*", a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069) Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Pulmonary hypertension in ankylosing spondylitis Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR). Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Development and improvement of single-stage surgical treatments of patients with spondylitis and pulmonary and pleural TB Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Rate of occurrence of lung function testing abnormalities in Greek ankylosing spondylitis patients Source: Annual Congress 2013 –New issues in lung function testing Year: 2013 Cluster analyses in a sample of COPD patients Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1 Year: 2014 Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020 30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS) Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015